Travere Therapeutics, Inc. (TVTX) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $133.59M2017: $154.94M2018: $164.25M2019: $175.34M2020: $198.32M2021: $131.84M2022: $109.46M2023: $145.24M2024: $233.18M2025: $490.73M$490.73M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$490.73M+110.5%
2024$233.18M+60.5%
2023$145.24M+32.7%
2022$109.46M-17.0%
2021$131.84M-33.5%
2020$198.32M+13.1%
2019$175.34M+6.8%
2018$164.25M+6.0%
2017$154.94M+16.0%
2016$133.59M